Global Maternal Health Market Size, Share, Trends, Industry Growth by Pregnancy Type (Intrauterine, Ectopic, Tubal, Others), by Complication (Miscarriage, Premature Labor & Birth, Preeclampsia, Gestational Diabetes, Placenta Previa, Others), by Care, by Region and Forecast to 2030
Report ID: RC41596 | Report Format: PDF + Excel | Starting Price: 3600/- USD |Key Findings:
- The market is experiencing a robust growth rate of over 11% over the forecast period to 2030
- By pregnancy type, the intrauterine segment dominated the global market in 2023
- Geographically, North America accounted to hold the largest market share in the benchmark year 2023
The global maternal health market is anticipated to grow at a robust CAGR of over 11% during the forecast period from 2024 to 2030. The increasing awareness and emphasis on maternal health and well-being have led to higher demand for comprehensive maternal care services. Advancements in medical technology, such as improved diagnostic and therapeutic devices, have enhanced the quality of care available to expectant mothers. Government initiatives and healthcare policies focused on reducing maternal and infant mortality rates have also played a significant role in driving the market. Additionally, the rising prevalence of pregnancy-related complications, such as gestational diabetes and pre-eclampsia, has necessitated better maternal health services. The growing global population, along with increased healthcare spending and improved access to healthcare facilities, particularly in developing regions, further fuels the growth of the maternal health market.
Market Snapshot:
Benchmark Year | 2023 | ||
Market Size | lock | ||
Market Growth (CAGR) | > 11% (2024 – 2030) | ||
Largest Market Share | North America | ||
Analysis Period | 2020-2030 | ||
Market Players | Johnson & Johnson Private Limited, Jiovio Healthcare, MedTech Boston, Merck & Co., Inc., RAND Corporation, and SYNAPSE Product Development |
To know more about the research study, request sample papers
Market Trends:
Technological Advancements: The integration of advanced technologies into maternal health care is revolutionizing the way care is delivered. Telehealth platforms are enabling remote consultations and continuous monitoring, providing expectant mothers with access to medical advice and support from the comfort of their homes. Wearable devices, such as smartwatches and biosensors, track vital signs and fetal health, allowing for real-time data collection and early detection of potential issues. AI-powered diagnostics are improving the accuracy and speed of identifying complications, enabling timely interventions. These technological innovations are particularly beneficial in remote and underserved areas, where access to healthcare facilities may be limited.
Increased Focus on Preventive Care: There is a growing emphasis on preventive care in maternal health, aimed at ensuring healthier pregnancies and reducing the risk of complications. This includes routine screenings for conditions such as gestational diabetes, hypertension, and pre-eclampsia. Prenatal vitamins and supplements are increasingly recommended to address nutritional deficiencies and support fetal development. Lifestyle interventions, such as promoting healthy diets and physical activity, are also becoming more common. Preventive care not only improves maternal and fetal outcomes but also reduces healthcare costs by avoiding the need for more intensive treatments later on.
Rise in Government Initiatives and Programs: Governments and international organizations are playing a crucial role in driving improvements in maternal health. Many countries have launched initiatives and programs focused on reducing maternal and infant mortality rates. These efforts often include funding for healthcare facilities, training for healthcare providers, and public education campaigns. International organizations, such as the World Health Organization (WHO) and the United Nations (UN), are also actively involved in promoting maternal health through global initiatives and partnerships. These efforts are critical in ensuring that maternal health services reach the most vulnerable populations.
Growing Awareness and Education: Increased awareness and education about maternal health are leading to higher utilization of maternal health services. Public health campaigns and community outreach programs are informing expectant mothers about the importance of prenatal and postnatal care. Education efforts are also aimed at partners, families, and communities, emphasizing the role of support networks in maternal health. As a result, more women are seeking regular check-ups, following medical advice, and accessing available resources to ensure healthy pregnancies and deliveries.
Expansion of Telehealth Services: The COVID-19 pandemic has accelerated the adoption of telehealth services, and this trend is continuing in the maternal health market. Telehealth allows pregnant women to access medical consultations and support without the need for in-person visits, which is especially valuable in remote and underserved areas. Telehealth platforms offer various services, including virtual prenatal visits, remote monitoring of vital signs, and mental health support. This expansion of telehealth services improves accessibility and convenience, ensuring that more women receive timely and adequate care.
Market Opportunities:
The global maternal health market presents significant opportunities for growth and innovation, driven by the increasing demand for comprehensive maternal care and the integration of advanced technologies. There is substantial potential in expanding telehealth services, which can provide remote monitoring and consultations to underserved and rural populations, thereby improving access to care. The development of AI-powered diagnostic tools and wearable health devices offers opportunities to enhance early detection and management of pregnancy-related complications. Additionally, the rising focus on mental health care for expectant and new mothers opens avenues for specialized counseling and support services. The market also benefits from government initiatives and increased healthcare funding aimed at reducing maternal and infant mortality rates, creating a favorable environment for investment and expansion in maternal health services and products.
Market Restraints:
Despite the growth and opportunities in the global maternal health market, several restraints pose challenges to its expansion. One significant barrier is the high cost of advanced maternal health technologies and services, which can limit accessibility, particularly in low- and middle-income regions. Additionally, disparities in healthcare infrastructure and resources between urban and rural areas can lead to uneven access to quality maternal care. Limited awareness and education about the importance of maternal health services in certain communities can result in underutilization of available resources. Cultural and societal norms in some regions may also hinder women from seeking necessary prenatal and postnatal care. Furthermore, regulatory hurdles and stringent approval processes for new maternal health products and services can delay market entry and innovation.
Market Insights:
The global maternal health market is bifurcated into pregnancy type, complication, care, and geography. On the basis of pregnancy type, the intrauterine pregnancy segment dominated the market in 2023, which represents the majority of pregnancies. This segment encompasses routine prenatal and postnatal care, including regular check-ups, nutritional support, and diagnostic screenings such as ultrasounds and blood tests. The widespread nature of intrauterine pregnancies drives the demand for a broad range of maternal health services and products, from prenatal vitamins to childbirth and postnatal care services. The advancements in prenatal diagnostics and non-invasive prenatal testing (NIPT) further bolster this segment, offering safer and more accurate ways to monitor the health of both the mother and the fetus. The emphasis on personalized care plans tailored to individual health needs also enhances the quality of care provided, making it the largest and most significant segment in the maternal health market.
Intrauterine pregnancies benefit from extensive government support and healthcare policies aimed at ensuring maternal and child health, contributing to the segment’s dominance. Initiatives such as public health campaigns, funding for prenatal care programs, and improved access to healthcare facilities have significantly increased awareness and utilization of maternal health services. The growing availability of telehealth services has also made it easier for women in remote or underserved areas to access prenatal care, further expanding the reach of this segment. As a result, the intrauterine pregnancy segment not only dominates in terms of market size but also sets the standard for maternal health care quality and accessibility, driving continuous innovation and improvement within the maternal health market.
The maternal health market research report presents the analysis of each segment from 2020 to 2030 considering 2023 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2024 to 2030.
Historical & Forecast Period
- 2020-22 – Historical Year
- 2023 – Base Year
- 2024-2030 – Forecast Period
Market Segmentation:
By Pregnancy Type:
- Intrauterine
- Ectopic
- Tubal
- Others
By Complication:
- Miscarriage
- Premature Labor & Birth
- Preeclampsia
- Gestational Diabetes
- Placenta Previa
- Others
By Care:
- Prenatal Care
- Postnatal Care
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Regional Analysis:
Geographically, the dominant region in the global maternal health market is typically North America, driven by advanced healthcare infrastructure, high healthcare expenditure, and robust government support for maternal and child health initiatives. In North America, countries like the United States and Canada have well-established healthcare systems that prioritize maternal care through comprehensive prenatal and postnatal services. These services include routine check-ups, prenatal screenings, advanced diagnostic tools, and specialized care for high-risk pregnancies. Moreover, the region benefits from a strong focus on research and development in maternal health, leading to continuous advancements in medical technologies and treatments. The availability of private healthcare facilities and insurance coverage also contributes to the dominance of North America in the maternal health market, ensuring widespread access to quality maternal care services.
In addition to North America, Europe also holds a significant share in the maternal health market. Countries across Western Europe, such as the United Kingdom, Germany, and France, prioritize maternal health through well-funded healthcare systems and comprehensive social support programs. These countries offer universal healthcare coverage, which includes maternal health services as part of basic healthcare provisions. The presence of leading pharmaceutical companies, research institutions, and academic centers focused on maternal health further strengthens Europe’s position in the global market. The region’s emphasis on evidence-based medicine, coupled with proactive government policies promoting maternal health, underscores Europe’s role as a dominant force in shaping advancements and standards of care in maternal health globally.
Competitive Landscape:
Some of the prominent market players operating in the global maternal health market are Johnson & Johnson Private Limited, Jiovio Healthcare, MedTech Boston, Merck & Co., Inc., RAND Corporation, and SYNAPSE Product Development. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.
Key Companies:
- Johnson & Johnson Private Limited
- Jiovio Healthcare
- MedTech Boston
- Merck & Co., Inc.
- RAND Corporation
- SYNAPSE Product Development
- Siemens
- Agile Therapeutics
- Fuji Latex Co
- Okamoto Industries Inc.
- Reckitt Benckiser Group Plc
- Sanofi
Key Questions Answered by Maternal Health Market Report
- Global maternal health market forecasts from 2024-2030
- Regional market forecasts from 2024-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
- Country-level forecasts from 2024-2030 covering 15 major countries from the regions as mentioned above
- Maternal health submarket forecasts from 2024-2030 covering the market by pregnancy type, complication, care, and geography
- Various industry models such as SWOT analysis, Value Chain Analysis about the market
- Analysis of the key factors driving and restraining the growth of the global, regional, and country-level maternal health markets from 2024-2030
- Competitive Landscape and market positioning of top 10 players operating in the market
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Maternal Health Market Portraiture
2.2. Global Maternal Health Market, by Pregnancy Type, 2023 (USD Mn)
2.3. Global Maternal Health Market, by Complication, 2023 (USD Mn)
2.4. Global Maternal Health Market, by Care, 2023 (USD Mn)
2.5. Global Maternal Health Market, by Geography, 2023 (USD Mn)
3. Global Maternal Health Market Analysis
3.1. Maternal Health Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Market Trends
3.5. Attractive Investment Proposition
3.6. Competitive Analysis
3.7. Porter’s Five Force Analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrants
3.7.4. Threat of Substitutes
3.7.5. Degree of Competition
3.8. PESTLE Analysis
4. Global Maternal Health Market by Pregnancy Type, 2020 – 2030 (USD Mn)
4.1. Overview
4.2. Intrauterine
4.3. Ectopic
4.4. Tubal
4.5. Others
5. Global Maternal Health Market by Complication, 2020 – 2030 (USD Mn)
5.1. Overview
5.2. Miscarriage
5.3. Premature Labor & Birth
5.4. Preeclampsia
5.5. Gestational Diabetes
5.6. Placenta Previa
5.7. Others
6. Global Maternal Health Market by Care, 2020 – 2030 (USD Mn)
6.1. Overview
6.2. Prenatal Care
6.3. Postnatal Care
7. North America Maternal Health Market Analysis and Forecast, 2020 – 2030 (USD Mn)
7.1. Overview
7.2. North America Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
7.3. North America Maternal Health Market by Complication, (2020-2030 USD Mn)
7.4. North America Maternal Health Market by Care, (2020-2030 USD Mn)
7.5. North America Maternal Health Market by Country, (2020-2030 USD Mn)
7.5.1. U.S.
7.5.1.1. U.S. Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
7.5.1.2. U.S. Maternal Health Market by Complication, (2020-2030 USD Mn)
7.5.1.3. U.S. Maternal Health Market by Care, (2020-2030 USD Mn)
7.5.2. Canada
7.5.2.1. Canada Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
7.5.2.2. Canada Maternal Health Market by Complication, (2020-2030 USD Mn)
7.5.2.3. Canada Maternal Health Market by Care, (2020-2030 USD Mn)
7.5.3. Mexico
7.5.3.1. Mexico Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
7.5.3.2. Mexico Maternal Health Market by Complication, (2020-2030 USD Mn)
7.5.3.3. Mexico Maternal Health Market by Care, (2020-2030 USD Mn)
8. Europe Maternal Health Market Analysis and Forecast, 2020 - 2030 (USD Mn)
8.1. Overview
8.2. Europe Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
8.3. Europe Maternal Health Market by Complication, (2020-2030 USD Mn)
8.4. Europe Maternal Health Market by Care, (2020-2030 USD Mn)
8.5. Europe Maternal Health Market by Country, (2020-2030 USD Mn)
8.5.1. Germany
8.5.1.1. Germany Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
8.5.1.2. Germany Maternal Health Market by Complication, (2020-2030 USD Mn)
8.5.1.3. Germany Maternal Health Market by Care, (2020-2030 USD Mn)
8.5.2. U.K.
8.5.2.1. U.K. Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
8.5.2.2. U.K. Maternal Health Market by Complication, (2020-2030 USD Mn)
8.5.2.3. U.K. Maternal Health Market by Care, (2020-2030 USD Mn)
8.5.3. France
8.5.3.1. France Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
8.5.3.2. France Maternal Health Market by Complication, (2020-2030 USD Mn)
8.5.3.3. France Maternal Health Market by Care, (2020-2030 USD Mn)
8.5.4. Spain
8.5.4.1. Spain Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
8.5.4.2. Spain Maternal Health Market by Complication, (2020-2030 USD Mn)
8.5.4.3. Spain Maternal Health Market by Care, (2020-2030 USD Mn)
8.5.5. Italy
8.5.5.1. Italy Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
8.5.5.2. Italy Maternal Health Market by Complication, (2020-2030 USD Mn)
8.5.5.3. Italy Maternal Health Market by Care, (2020-2030 USD Mn)
8.5.6. Rest of Europe
8.5.6.1. Rest of Europe Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
8.5.6.2. Rest of Europe Maternal Health Market by Complication, (2020-2030 USD Mn)
8.5.6.3. Rest of Europe Maternal Health Market by Care, (2020-2030 USD Mn)
9. Asia Pacific Maternal Health Market Analysis and Forecast, 2020 - 2030 (USD Mn)
9.1. Overview
9.2. Asia Pacific Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
9.3. Asia Pacific Maternal Health Market by Complication, (2020-2030 USD Mn)
9.4. Asia Pacific Maternal Health Market by Care, (2020-2030 USD Mn)
9.5. Asia Pacific Maternal Health Market by Country, (2020-2030 USD Mn)
9.5.1. China
9.5.1.1. China Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
9.5.1.2. China Maternal Health Market by Complication, (2020-2030 USD Mn)
9.5.1.3. China Maternal Health Market by Care, (2020-2030 USD Mn)
9.5.2. Japan
9.5.2.1. Japan Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
9.5.2.2. Japan Maternal Health Market by Complication, (2020-2030 USD Mn)
9.5.2.3. Japan Maternal Health Market by Care, (2020-2030 USD Mn)
9.5.3. India
9.5.3.1. India Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
9.5.3.2. India Maternal Health Market by Complication, (2020-2030 USD Mn)
9.5.3.3. India Maternal Health Market by Care, (2020-2030 USD Mn)
9.5.4. South Korea
9.5.4.1. South Korea Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
9.5.4.2. South Korea Maternal Health Market by Complication, (2020-2030 USD Mn)
9.5.4.3. South Korea Maternal Health Market by Care, (2020-2030 USD Mn)
9.5.5. Rest of Asia Pacific
9.5.5.1. Rest of Asia Pacific Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
9.5.5.2. Rest of Asia Pacific Maternal Health Market by Complication, (2020-2030 USD Mn)
9.5.5.3. Rest of Asia Pacific Maternal Health Market by Care, (2020-2030 USD Mn)
10. Latin America (LATAM) Maternal Health Market Analysis and Forecast, 2020 - 2030 (USD Mn)
10.1. Overview
10.2. Latin America Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
10.3. Latin America Maternal Health Market by Complication, (2020-2030 USD Mn)
10.4. Latin America Maternal Health Market by Care, (2020-2030 USD Mn)
10.5. Latin America Maternal Health Market by Country, (2020-2030 USD Mn)
10.5.1. Brazil
10.5.1.1. Brazil Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
10.5.1.2. Brazil Maternal Health Market by Complication, (2020-2030 USD Mn)
10.5.1.3. Brazil Maternal Health Market by Care, (2020-2030 USD Mn)
10.5.2. Argentina
10.5.2.1. Argentina Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
10.5.2.2. Argentina Maternal Health Market by Complication, (2020-2030 USD Mn)
10.5.2.3. Argentina Maternal Health Market by Care, (2020-2030 USD Mn)
10.5.3. Rest of Latin America
10.5.3.1. Rest of Latin America Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
10.5.3.2. Rest of Latin America Maternal Health Market by Complication, (2020-2030 USD Mn)
10.5.3.3. Rest of Latin America Maternal Health Market by Care, (2020-2030 USD Mn)
11. Middle East and Africa Maternal Health Market Analysis and Forecast, 2020 - 2030 (USD Mn)
11.1. Overview
11.2. MEA Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
11.3. MEA Maternal Health Market by Complication, (2020-2030 USD Mn)
11.4. MEA Maternal Health Market by Care, (2020-2030 USD Mn)
11.5. Middle East and Africa Maternal Health Market, by Country, (2020-2030 USD Mn)
11.5.1. GCC
11.5.1.1. GCC Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
11.5.1.2. GCC Maternal Health Market by Complication, (2020-2030 USD Mn)
11.5.1.3. GCC Maternal Health Market by Care, (2020-2030 USD Mn)
11.5.2. South Africa
11.5.2.1. South Africa Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
11.5.2.2. South Africa Maternal Health Market by Complication, (2020-2030 USD Mn)
11.5.2.3. South Africa Maternal Health Market by Care, (2020-2030 USD Mn)
11.5.3. Rest of MEA
11.5.3.1. Rest of MEA Maternal Health Market by Pregnancy Type, (2020-2030 USD Mn)
11.5.3.2. Rest of MEA Maternal Health Market by Complication, (2020-2030 USD Mn)
11.5.3.3. Rest of MEA Maternal Health Market by Care, (2020-2030 USD Mn)
12. Competitive Landscape
12.1. Company Market Share Analysis, 2023
12.2. Competitive Dashboard
12.3. Competitive Benchmarking
12.4. Geographic Presence Heatmap Analysis
12.5. Company Evolution Matrix
12.5.1. Star
12.5.2. Pervasive
12.5.3. Emerging Leader
12.5.4. Participant
12.6. Strategic Analysis Heatmap Analysis
12.7. Key Developments and Growth Strategies
12.7.1. Mergers and Acquisitions
12.7.2. New Product Launch
12.7.3. Joint Ventures
12.7.4. Others
13. Company Profiles
13.1. Johnson & Johnson Private Limited
13.1.1. Business Description
13.1.2. Financial Health and Budget Allocation
13.1.3. Product Positions/Portfolio
13.1.4. Recent Development
13.1.5. SWOT Analysis
13.2. Jiovio Healthcare
13.3. MedTech Boston
13.4. Merck & Co., Inc.
13.5. RAND Corporation
13.6. SYNAPSE Product Development
13.7. Siemens
13.8. Agile Therapeutics
13.9. Fuji Latex Co
13.10. Okamoto Industries Inc.
13.11. Reckitt Benckiser Group Plc
13.12. Sanofi
$ 6995/- Corporate License
Email: sales@researchcorridor.com
- Markets in over 100+ countries analyzed granularly
- 35% of our total client are returning clients
- 1000+ customers globally
- 100+ paid data sources mined to bring cutting-edge insights
- 24x5 availability - we are always there when you need us
- "Free of Cost Report Customization" is available
- Request a regional report at Best Price
- Overnight Face Mask Market Report
- Transthyretin Amyloidosis Treatment Market Report
- Polyethylene Terephthalate Market Report
- Hemostasis Valve Market Report
- Annuloplasty System Market Report
- Crop Duster Market Report
- Polynucleotides Injectable Market Report
- Polymer Stabilizers Market Report
- Gastrointestinal Therapeutics Market Report
- Functional Yogurt Market Report
- Breast Lesion Localization Devices Market Report
- Eyelash Serum Market Report